Correlation Between Cisco Systems and Humacyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cisco Systems and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cisco Systems and Humacyte, you can compare the effects of market volatilities on Cisco Systems and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and Humacyte.

Diversification Opportunities for Cisco Systems and Humacyte

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cisco and Humacyte is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Cisco Systems i.e., Cisco Systems and Humacyte go up and down completely randomly.

Pair Corralation between Cisco Systems and Humacyte

Given the investment horizon of 90 days Cisco Systems is expected to generate 0.29 times more return on investment than Humacyte. However, Cisco Systems is 3.49 times less risky than Humacyte. It trades about 0.09 of its potential returns per unit of risk. Humacyte is currently generating about -0.08 per unit of risk. If you would invest  6,959  in Cisco Systems on October 9, 2025 and sell it today you would earn a total of  513.00  from holding Cisco Systems or generate 7.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cisco Systems  vs.  Humacyte

 Performance 
       Timeline  
Cisco Systems 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Cisco Systems may actually be approaching a critical reversion point that can send shares even higher in February 2026.
Humacyte 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Humacyte has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors.

Cisco Systems and Humacyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cisco Systems and Humacyte

The main advantage of trading using opposite Cisco Systems and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.
The idea behind Cisco Systems and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Managers
Screen money managers from public funds and ETFs managed around the world
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets